Estrella Immunopharma, Inc.
ESLA
$0.94
-$0.0295-3.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -8.82M | -8.82M | -7.31M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 0.00 | 0.00 | 1.19M |
| Change in Net Operating Assets | -- | -- | -9.19M | -9.19M | -9.95M |
| Cash from Operations | -- | -- | -18.01M | -18.01M | -16.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 5.07M | 5.07M | 4.96M |
| Cash from Investing | -- | -- | 5.07M | 5.07M | 4.96M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 300.00K |
| Total Debt Repaid | -- | -- | -300.00K | -300.00K | -300.00K |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 10.00M |
| Repurchase of Common Stock | -- | -- | -5.58M | -5.58M | -5.43M |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 9.02M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.53M | -1.53M | -798.70K |
| Cash from Financing | -- | -- | -7.40M | -7.40M | 12.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -20.34M | -20.34M | 1.69M |